NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
1 hedge funds and large institutions have $112M invested in NxStage Medical Inc. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 171 closing their positions.
91% less funds holding in top 10
Funds holding in top 10: 11 → 1 (-10)
93% less capital invested
Capital invested by funds: $1.73B → $112M (-$1.62B)
99% less funds holding
Funds holding: 172 → 1 (-171)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 171
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$176M |
| 2 |
BlackRock
New York
|
-$155M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$105M |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$84.9M |
| 5 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$69.6M |
NXTM Hedge Fund Activity: Q1 2019 in Review
1 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q1 2019, worth a combined $112M — down 93% from $1.73B a quarter earlier.
Sellers outnumbered buyers: 171 funds closed out of NXTM and 0 opened new positions — a net loss of 171 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $176M sold.
- 1 institutional investor held NxStage Medical Inc. (NXTM) as of Q1 2019, down from 172 in Q4 2018.
- Funds reported $112M of NxStage Medical Inc. stock for Q1 2019, down 93% quarter-over-quarter.
- 0 funds opened new NxStage Medical Inc. positions in Q1 2019 and 171 closed out, a net change of -171 holders.
- The largest NxStage Medical Inc. seller in Q1 2019 was Vanguard Group, an estimated $176M sold.
Based on aggregated 13F filings for Q1 2019.